The Peptide Problem — Essential: The Pharmacy Compounding Podcast
Originally on
Pharmacy Podcast Network / APC · hosted by Andrew Caner
The guests
Tenil Davis
APC Chief Advocacy Officer
Matt Johnson
President, PharmaSource Direct
APC Chief Advocacy Officer Tenil Davis and PharmaSource Direct president Matt Johnson on why peptides went from allowed to banned.
In this episode
- How peptides became Category 2
- The FDA's PCAC meeting flaws
- API sourcing realities
- The six open seats that could flip the board
Listen & watch
Keep listening